What is Biogen's equity amortized cost?

Biogen (BIIB) reported equity amortized cost of $227.80M in Q1 2026.

How has Biogen's equity amortized cost changed year-over-year?

Biogen's equity amortized cost decreased by 65.9% year-over-year, from $668.70M to $227.80M.

What is the long-term trend for Biogen's equity amortized cost?

Over 5 years (2020 to 2025), Biogen's equity amortized cost has grown at a -28.7% compound annual growth rate (CAGR), from $1.24B to $227.70M.

Discontinued — last reported Q4 '21

Non-Current Assets

Equity Amortized Cost

Biogen Equity Amortized Cost increased by 0.0% to $227.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 65.9%, from $668.70M to $227.80M. Over 5 years (FY 2020 to FY 2025), Equity Amortized Cost shows a downward trend with a -28.7% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

First reportedQ4 2018

Last reportedQ4 2021

Metric ID: equity_amortized_cost

Historical Data

19 periods

	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$1.17B	$1.17B	$1.17B	$1.14B	$1.13B	$1.13B	$1.09B	$1.00B	$993.30M	$979.90M	$928.40M	$800.20M	$734.30M	$668.70M	$668.70M	$668.70M	$227.80M	$227.70M	$227.80M
QoQ Change	—	-0.2%	+0.0%	-2.6%	-0.3%	+0.0%	-4.0%	-8.1%	-0.8%	-1.3%	-5.3%	-13.8%	-8.2%	-8.9%	+0.0%	+0.0%	-65.9%	-0.0%	+0.0%
YoY Change	—	—	—	—	-3.0%	-2.8%	-6.7%	-12.0%	-12.4%	-13.6%	-14.7%	-20.1%	-26.1%	-31.8%	-28.0%	-16.4%	-69.0%	-65.9%	-65.9%

Range$227.70M – $1.17B

CAGR-30.5%

Avg YoY Growth-25.9%

Median YoY Growth-16.4%

Frequently Asked Questions

What is Biogen's equity amortized cost?: Biogen (BIIB) reported equity amortized cost of $227.80M in Q1 2026.
How has Biogen's equity amortized cost changed year-over-year?: Biogen's equity amortized cost decreased by 65.9% year-over-year, from $668.70M to $227.80M.
What is the long-term trend for Biogen's equity amortized cost?: Over 5 years (2020 to 2025), Biogen's equity amortized cost has grown at a -28.7% compound annual growth rate (CAGR), from $1.24B to $227.70M.